Archive for News

MARY CROWLEY CANCER RESEARCH ADDS ED MARX TO BOARD OF DIRECTORS

Mary Crowley Cancer Research (MCCR) announced today the addition of Edward Marx to their Board of Directors.

MARY CROWLEY NEWSLETTER: VOLUME 12, ISSUE 2

MARY CROWLEY NEWSLETTER: VOLUME 12, ISSUE 1

MARY CROWLEY NEWSLETTER: VOLUME 11, ISSUE 3

MARY CROWLEY NEWSLETTER: VOLUME 11, ISSUE 2

MARY CROWLEY NEWSLETTER: VOLUME 11, ISSUE 1

MARY CROWLEY NEWSLETTER: VOLUME 10, ISSUE 4

EXPANDING THERAPIES FOR PROSTATE CANCER

The prostate is a hormonally regulated organ and prostate cancer is reliant on androgen receptor signaling for growth. The treatment of advanced prostate cancer has thus traditionally focused on the inhibition of androgen signaling.

MARY CROWLEY NEWSLETTER: VOLUME 10, ISSUE 3

MARY CROWLEY NEWSLETTER: VOLUME 10, ISSUE 2